Immediate release three-layered chewing gum tablets of fenoprofen calcium: preparation, optimization and bioavailability studies in healthy human volunteers

被引:6
作者
El Assassy, A. E. [1 ]
Amin, M. M. [1 ]
Abdelbary, A. A. [1 ]
机构
[1] Cairo Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Al Jizah, Egypt
关键词
Direct compression; multilayered tablet; beta-cyclodextrin complexation; water soluble polymer; chewing gum; HYDROXYPROPYL-BETA-CYCLODEXTRIN; WATER-SOLUBLE POLYMERS; IN-VITRO DISSOLUTION; RELATIVE BIOAVAILABILITY; INCLUSION-COMPOUNDS; PHYSICOCHEMICAL PROPERTIES; DISINTEGRATING TABLETS; COMPLEXATION; DRUG; HYDROCHLORIDE;
D O I
10.3109/03639045.2011.620967
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A three-layered gum tablet (1800 mg), containing 200 mg of Fenoprofen Calcium (Fn) with an inner core containing the drug, and two external layers containing antiadherent lubricant, has been prepared using direct compression. A 23 factorial plan has been designed to evaluate the effect of formulation variables namely, Pharmagum (R) M concentration, Maltodextrin type, and Co-adjuvant type on the release characteristics of Fn from the prepared tablets. The formula consisting of 65% Pharmagum (R) M, 75% Maltodextrin DE 39 and 5% Talc comparatively exhibited the highest release (66.59% +/- 2.39) in the mouth after 5 min of chewing. Binary and ternary beta-cyclodextrin (beta-CD) complexation was adopted to enhance the release of Fn from the selected gum tablet. The highest significant release (p < 0.05) was achieved from the lyophilized ternary complex containing 100 mg of Fn in presence of polyvinylpyrrolidone (PVP K-25), exhibiting a release of 88.25% +/- 0.93 after 5 min of chewing. The relative bioavailability of the selected gum tablet was found to be 166.06% compared to Nalfon (R) 200 mg capsules. Reduction of the dose to 100 mg exhibited faster absorption rate than Nalfon (R) capsules. The obtained results suggest the possibility of reducing the dose of Fn in chewing gum.
引用
收藏
页码:603 / 615
页数:13
相关论文
共 48 条
[1]  
ABELSON D C, 1990, Journal of Clinical Dentistry, V2, P3
[2]   Effect of cyclodextrins on the physicochemical properties and antimycotic activity of clotrimazole [J].
Ahmed, MO ;
El-Gibaly, I ;
Ahmed, SM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 171 (01) :111-121
[3]   Effect of Aerosil® on the properties of lipid controlled release microparticles [J].
Albertini, B ;
Passerini, N ;
González-Rodríguez, ML ;
Perissutti, B ;
Rodriguez, L .
JOURNAL OF CONTROLLED RELEASE, 2004, 100 (02) :233-246
[4]   Improvement of the in vitro dissolution of praziquantel by complexation with α-, β- and γ-cyclodextrins [J].
Becket, G ;
Schep, LJ ;
Tan, MY .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 179 (01) :65-71
[5]   DETERMINANTS OF NICOTINE INTAKE WHILE CHEWING NICOTINE POLACRILEX GUM [J].
BENOWITZ, NL ;
JACOB, P ;
SAVANAPRIDI, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (04) :467-473
[6]   Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques [J].
Betageri, GV ;
Makarla, KR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 126 (1-2) :155-160
[7]  
Bhargava S., 2008, Current Drug Delivery, V5, P1
[8]   Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir [J].
Boudad, H ;
Legrand, P ;
Lebas, G ;
Cheron, M ;
Duchêne, D ;
Ponchel, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 218 (1-2) :113-124
[9]  
BOUSQUET E, 1992, PHARMAZIE, V47, P607
[10]   INTERACTION OF NAPROXEN WITH BETA-CYCLODEXTRIN IN GROUND MIXTURE [J].
CELEBI, N ;
ERDEN, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 78 (2-3) :183-187